FDA Inspection 1182406 — Hospital Of The University of Pennsylvania

Hospital Of The University of Pennsylvania — FEI 2571117

The FDA completed an inspection of Hospital Of The University of Pennsylvania on October 14, 2022 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 14, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Philadelphia, PA (United States)